Literature for peptidase C30.005: SARS coronavirus picornain 3C-like peptidase

(References are filtered for relevance to Review. To remove the filter click here. See explanation.)

2021
1. Sharma,A., Kaliya,K. and Maurya,S.K.
   Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses
   Curr Top Med Chem21, 307-328. PubMed  Europe PubMed DOI  V
2014
2. Hilgenfeld,R.
   From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
   FEBS J281, 4085-4096. PubMed  Europe PubMed DOI  V  S
2011
3. Xia,B. and Kang,X.
   Activation and maturation of SARS-CoV main protease
   Protein Cell2, 282-290. PubMed  Europe PubMed DOI  V
2010
4. Steuber,H. and Hilgenfeld,R.
   Recent advances in targeting viral proteases for the discovery of novel antivirals
   Curr Top Med Chem10, 323-345. PubMed  Europe PubMed DOI  V
2006
5. Yang,H., Bartlam,M. and Rao,Z.
   Drug design targeting the main protease, the Achilles' heel of coronaviruses
   Curr Pharm Des12, 4573-4590. PubMed  Europe PubMed DOI  V
2004
6. Denison,M.R.
   Coronavirus picornain-like cysteine proteinase
   [ISSN:0-12-079610-4]2, 1382-1385.  V